Diuretics in renal failure

Mineral and Electrolyte Metabolism

Volumn 25, Issue 1-2, 1999, Pages 32-38

  Andreucci, Michele ^b   Russo, Domenico ^b   Fuiano, Giorgio ^b   Minutolo, Roberto ^b   Andreucci, Vittorio E ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

Amiloride; Chronic renal failure; Diuretic resistance; Diuretics; Furosemide; Thiazide; Torasemide

Indexed keywords

ALBUMIN; AMILORIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ARTICLE; DIURESIS; FLUID RETENTION; GLOMERULUS FILTRATION; HEART FUNCTION; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOMAGNESEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; NEPHROSIS; PRIORITY JOURNAL; SODIUM BALANCE; UREMIA;

CHRONIC DISEASE; DIURETICS; DRUG RESISTANCE; EDEMA; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY; SODIUM; UREMIA;

EID: 0032916244     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057416     Document Type: Article

References (51)

1. Andreucci VE: Chronic renal failure; in Castro JE (ed): The Treatment of Renal Failure. Lancaster, MTP Press. 1982, pp 33-167.
2. Coleman TG, Bower JD, Guyton AC: Hypertension caused by salt loading in the dog. Onset transients of cardiac output and other circulatory variables. Circ Res 1969;25:153-160.
3. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Normann RA: Arterial pressure regulation. Overriding dominance of the kidneys in the long-term regulation and hypertension. Am J Med 1972;52:584-594.
4. Russo D, Minutolo R, Andreucci VE: The place of loop diuretics in chronic renal failure. Cardiology 1994;84(suppl 2):162-170.
5. Swartz CD, Kim KE: Management of hypertension in the patients with chronic renal failure; in Onesti G, Brest NA (eds): Hypertension: Mechanism, Diagnosis, and Treatment. Philadelphia, Davis, 1978, pp 263-272.
6. Voelker J, Cartwright-Brown D, Anderson S, Leinfielder J, Sica D, Kokko J, Brater D: Comparison of loop diuretics in patients with chronic renal failure. Kidney Int 1987;32:572-578.
7. Weidmann P, Beretta-Piccoli C: Chronic renal failure and hypertension; in Robertson JIR (ed): Handbook of Hypertension. Clinical Aspects of Secondary Hypertension. Amsterdam, Elsevier Science, 1983, pp 80-131.
8. Andreucci VE, Russo D: The use of loop diuretics in chronic renal failure. Positive effects and drawbacks. Prog Pharmacol Clin Pharmacol 1992;9:577-595.
9. Dal Canton A, Russo D, Gallo R, Ardillo G, Trevico S, Cianciaruso B, Andreucci VE: Diuretic therapy in uremic patients. Kidney Int 1985;28(suppl 17):154-156.
10. Russo D, Gazzotti MR, Testa A: Torasemide, a new loop diuretic, in patients with chronic renal failure. Nephron 1990;55:141-145.
11. Andreucci VE, Russo D, Memoli B, Testa A, Rampino T, Gazzotti RM: Efficacy of i.v. torasemide in the treatment of acute and chronic high grade renal failure. Prog Pharmacol Clin Pharmacol 1990;8:229-238.
12. Russo D, Memoli B, Andreucci VE: The place of loop diuretics in the treatment of acute and chronic renal failure. Clin Nephrol 1992; 38(suppl):69-73.
13. Yen PPY, Tomko DS, Stacy WK, Rears ES, Haden HT, Falls WF: Factors influencing sodium and water excretion in uremic man. Kidney Int 1975;7:103-110.
14. Hook JB, Williamson HE: Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide. J Pharmacol Exp Ther 1965;149:404-408.
15. Weiner MI, Mudge HG: Diuretics and other agents employed in the mobilization of edema fluid; in Goodmann SL, Gilman GA (eds): The Pharmacological Basis of Therapeutics. New York, MacMillan, 1985, pp 887-907.
16. Rose BD: Diuretics. Kidney Int 1991;39:336-352.
17. Brater D, Anderson D, Brown-Cartwright D: Response to furosemide in chronic renal insufficiency: Rational for limited doses. Clin Pharmacol Ther 1986;40:134-139.
18. Brater DC: Use of diuretics in chronic renal insufficiency and nephrotic syndrome. Semin Nephrol 1988;8:333-341.
19. Rudy D, Voelker J, Greene P, Esparza F, Brater D: Loop diuretics for chronic renal insufficiency: A continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115:360-366.
20. Knauf H, Spahn H, Mutschler E: The loop diuretic torasemide in chronic renal failure, pharmacokinetics and pharmacodynamics, Drugs 1991;41(suppl 3):23-34.
21. Ghys A, Denef J, de Suray JM: Pharmacological properties of the new potent diuretic torasemide in rats and dogs. Arzneimittelforschung 1985; 35:152-155.
22. Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A: Torasemide, a new potent diuretic. A double-blind comparison with furosemide. Eur J Clin Pharmacol 1986;31:29-34.
23. Lesne M, Clercks-Braun F, Dohoux P, van Yperselede Strihou CH: Pharmacokinetic study of torasemide in humans. Eur J Clin Pharmacol 1986;20:382-397.
24. Dal Canton A, Fuiano G, Conte G, Terribile M, Sabbatini M, Cianciaruso B, Andreucci VE: Mechanism of increased plasma urea after diuretic therapy in uremic patients. Clin Sci 1985; 68:255-261.
25. Risler T, Kramer B, Muller GA: The efficacy of diuretics in acute and chronic renal failure. Drugs 1991;41(suppl 3):69-79.
26. Green T, Mirkin B: Resistance of proteinuric rats to furosemide. Urinary drug protein binding as a determinant to drug effect. Life Sci 1980;26:623-630.
27. Fliser D: Loop diuretics and thiazides - The case for their combination in chronic renal failure. Nephrol Dial Transplant 1996;11:408-423.
28. Andreucci VE: Use of diuretics in chronic renal failure. Am J Kidney Dis 1997;30:XIII-XV.
29. Keller E, Hoppe-Seyler G, Schollmeyer P: Disposition and diuretic effect of furosemide in nephrotic syndrome. Clin Pharmacol Ther 1982 32:442-449.
30. Smith D, Hyneck M, Berardi R, Port F: Urinary protein binding, kinetics and dynamics of furosemide in nephrotic patients. J Pharmaceut Sci 1985;74:603-607.
31. Kirchner K: Mechanisms of diuretic resistance in nephrotic syndrome; in Puschett J, Greenberg A (eds): Diuretics IV. Chemistry, Pharmacology and Clinical Applications. Amsterdam, Elsevier, 1993. pp 435-443.
32. Boesken WH, Kult J: High-dose torasemide, given once daily intravenously for one week, in patients with advanced chronic renal failure. Clin Nephrol 1997;48:22-28.
33. Kuhn K, Haas-Wohrle A, Lutz-Vorderbrugge, Felten H: Treatment of severe nephrotic syndrome. Kidney Int 1998;53(suppl 64):50-53.
34. Ritz E, Strzelczyk P: The alcoholic patient with an acute nephrotic syndrome and resistance to diuretics. Nephrol Dial Transpl 1997;12:2455 2458.
35. Glassock RJ: Management of intractable edema in nephrotic syndrome. Kidney Int 1997; 51(suppl 58):75-79.
36. Dal Canton A, Russo D, Gallo R, Conte G, Andreucci VE: Muzolimine: A new high-ceiling diuretic suitable for patients with advanced renal disease. Br Med J 1981;282:595-598.
37. Ritz E, Fliser D, Nowicki M, Stein G: Treatment with high doses of loop diuretics in chronic renal failure. Nephrol Dial Transplant 1994;3:40-43.
38. Patel AR, Kirchner KA: Use of diuretics in chronic renal disease and nephrotic syndrome; in Seldin DW, Giebisch G (eds): Diuretic Agents. San Diego, Academic Press, 1997, pp 233-246.
39. Wollam G, Tarazi R, Bravo E, Dustan H: Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med 1982;72:929-938.
40. Knauf H, Mutschler E: Low dose segmental blockade of the nephron rather than high dose diuretic monotherapy; in Puschett J, Greenberg A (eds): Diuretics. IV. Chemistry, Pharmacology and Clinical Applications. Amsterdam, Elsevier, 1993, pp 449-456.
41. Fliser D, Schroter M, Neubeck M, Ritz E: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994;46:482-488.
42. Knauf H, Mutschler E: Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995;26:394-400.
43. Suki WN: Use of diuretics in chronic renal failure. Kidney Int 1997;51(suppl 59):33-35.
44. Cakalaroski K, Ivanovski N, Grozdanovski R, Ristovska V, Polenakovic M: Long-term diuretic therapy in patients with chronic renal failure. Clin Nephrol 1997;48:56-58.
45. Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y: Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 1987;32:198-203.
46. Stolear I, Achhammer L, Georges B: Efficacy of torasemide in the treatment of patients with high grade renal failure on dialysis. Prog Pharmacol Clin Pharmacol 1990;8:261-267.
47. Schuk W, Dorfler A, Stiehl L, Achhammer L: Double blind clinical trial investigating the efficacy and long term tolerance of torasemide 200 mg p.o. compared with furosemide 500 mg p.o. in patients with chronic renal failure on haemodialysis, a multi-centre study. Prog Pharmacol Clin Pharmacol 1990;8:249-257.
48. Van Olden R, van Meyel J, Gerlag P: Acute and long term effects of therapy with high dose furosemide in chronic hemodialysis patients. Am J Nephrol 1992;12:351-356.
49. Kamm DE, Wu L, Kuchmy B: Increased urea production is a major factor in the azotemia of diuretic induced sodium depletion. Kidney Int 1981;19:205.
50. Kokko JP: Urea transport in the proximal tubule and the ascending limb of Henle. J Clin Invest 1972;51:1999-2008.
51. Goldberg M, Wojtczak AM, Ramirez MA: Uphill transport of urea in the dog kidney: Effects of certain inhibitors. J Clin Invest 1967;46:388-399.